Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Citations for PubMed (Select 22064563)

1.

Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey.

Bailey DB Jr, Raspa M, Bishop E, Olmsted M, Mallya UG, Berry-Kravis E.

J Dev Behav Pediatr. 2012 Jan;33(1):62-9. doi: 10.1097/DBP.0b013e318236c0e1.

PMID:
22064563
2.

Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey.

Kronk R, Bishop EE, Raspa M, Bickel JO, Mandel DA, Bailey DB Jr.

Sleep. 2010 May;33(5):679-87.

3.

Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey.

Bailey DB Jr, Raspa M, Olmsted M, Holiday DB.

Am J Med Genet A. 2008 Aug 15;146A(16):2060-9. doi: 10.1002/ajmg.a.32439.

PMID:
18570292
4.
5.

The behavioral phenotype of FMR1 mutations.

Boyle L, Kaufmann WE.

Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):469-76. doi: 10.1002/ajmg.c.30277. Review.

PMID:
20981777
7.

[Medical treatment of fragile X syndrome].

Artigas-Pallarés J, Brun-Gasca C.

Rev Neurol. 2001 Oct;33 Suppl 1:S41-50. Spanish.

8.

Anxiety, attention problems, hyperactivity, and the Aberrant Behavior Checklist in fragile X syndrome.

Wheeler A, Raspa M, Bann C, Bishop E, Hessl D, Sacco P, Bailey DB Jr.

Am J Med Genet A. 2014 Jan;164A(1):141-55. doi: 10.1002/ajmg.a.36232. Epub 2013 Nov 25.

PMID:
24352914
9.

Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R.

J Dev Behav Pediatr. 2006 Apr;27(2 Suppl):S137-44.

PMID:
16685180
10.

Therapy service use among individuals with fragile X syndrome: findings from a US parent survey.

Martin GE, Ausderau KK, Raspa M, Bishop E, Mallya U, Bailey DB Jr.

J Intellect Disabil Res. 2013 Sep;57(9):837-49. doi: 10.1111/j.1365-2788.2012.01608.x. Epub 2012 Sep 14.

PMID:
22974130
11.

Teaching children with attention deficit hyperactivity disorder (ADHD) and autistic disorder (AD) how to swallow pills.

Beck MH, Cataldo M, Slifer KJ, Pulbrook V, Guhman JK.

Clin Pediatr (Phila). 2005 Jul-Aug;44(6):515-26.

PMID:
16015399
12.

Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.

Tsiouris JA, Brown WT.

CNS Drugs. 2004;18(11):687-703. Review.

PMID:
15330685
13.
14.

Fragile X syndrome: a psychiatric perspective.

Tranfaglia MR.

Results Probl Cell Differ. 2012;54:281-95. doi: 10.1007/978-3-642-21649-7_16.

PMID:
22009359
15.
16.

Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.

Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B.

J Abnorm Child Psychol. 2008 Jan;36(1):117-28. Epub 2007 Aug 3.

PMID:
17674186
17.

Self-injurious behavior and fragile X syndrome: findings from the national fragile X survey.

Symons FJ, Byiers BJ, Raspa M, Bishop E, Bailey DB.

Am J Intellect Dev Disabil. 2010 Nov;115(6):473-81. doi: 10.1352/1944-7558-115.6.473.

PMID:
20946000
18.

A controlled trial of stimulant medication in children with the fragile X syndrome.

Hagerman RJ, Murphy MA, Wittenberger MD.

Am J Med Genet. 1988 May-Jun;30(1-2):377-92.

PMID:
3052064
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk